Clever Culture Systems Limited (ASX:CC5)

Market Cap	26.49M
Revenue (ttm)	3.37M
Net Income (ttm)	-799.00K
Shares Out	1.77B
EPS (ttm)	-0.00
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	720,132
Open	0.0150
Previous Close	0.0150
Day's Range	0.0150 - 0.0150
52-Week Range	0.0120 - 0.0260
Beta	1.79
RSI	46.37
Earnings Date	Apr 29, 2025

About Clever Culture Systems

Clever Culture Systems Limited engages in the research, development, and commercialization of technology solutions for medical industry in Australia, the United States, Sweden, the United Kingdom, and Germany. The company offers Automated Plate Assessment System (APAS) Independence, a solution that automates the imaging, analysis, and interpretation of microbiology culture plates primarily for microbiology laboratories and pharmaceutical manufacturing sector; APAS Analysis Modules, a software algorithm that enables the screening of microbiology...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 2004
• Employees: 19
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: CC5

Financial Performance

In 2024, Clever Culture Systems's revenue was 1.26 million, a decrease of -41.09% compared to the previous year's 2.13 million. Losses were -3.74 million, -83.40% less than in 2023.